EGFR检测在肺癌中的临床意义

424 参考文献:

Suppl14):45-54.

[17]　LaiWW,ChenFF,WuMH,etal.Immunohistochemicalanalysisof

epidermalgrowthfactorreceptorfamilymembersinstageInon2smalcelllungcancer[J].AnnThoracSurg,2001,72(6):1868-1876.

[18]　AbeY,SagawaT,SakaiK,etal.Enzyme2linkedimmunosorbentassay

(ELISA)forhumanepidermalgrowthfactor(hEGF)[J].ClinChimActa,168(1):87-[H,Y,etal.Elevatedserumepidermal

withlymphnodemetastasisin].IntJClinOncol,2003,8(2):79-82.

]　PfeifferP,NexoE,BentzenSM,etal.Enzyme2linkedimmuno2sorbent

assayofepidermalgrowthfactorreceptorinlungcancer:comparisonswithimmunohistochemistry,clinico2pathologicalfeaturesandprognosis[J].BrJCncer,1998,78(1):96-99.

[21]　ClarkeLE,LeitzelK,SmithJ,etal.Epidermalgrowthfactorreceptor

mRNAinperipheralbloodofpatientswithpancreatic,lung,andcoloncarcinomasdetectedbyRT2PCR[J].IntJOncol,2003,22(2):425-430.

[22]　JanBrabender,KathleenD,Danenberg,etal.EpidermalGrowthFac2

torReceptorandHER2-neumRNAExpressioninNon2SmallCellLungCancerisCorrelatedwithSurvival[J].ClinicalCancerRe2search,2001,7(7):1850-1855.

[23]　SantosRomeoM,SokolovaIA,MorrisonLE,etal.Chromosomalab2

normalitiesinnon2smallcelllungcarcinomasandinbronchialepithe2liaofhigh2risksmokersdetectedbymulti2targetinterphasefluores2cenceinsituhybridization[J].JMolDiagn,2003,5(2):103-112.

[24]　GerdesAM,NielsenO,MohrU,etal.Correlationbetweenmolecular

geneticanalysesandimmunohistochemicalevaluationoftheepidermalgrowthfactorreceptorandp185HER2[J].AnticancerRes,1998,18(4A):2529-2534.

[25]　BaselgaJ.Newtechnologiesinepidermalgrowthfactorreceptor2target2

edcancertherapy[J].Signal,2000,1:12-21.

[26]　BaselgaJ,PfisterD,CooperMR,etal.PhaseIstudiesofanti2epider2

malgrowthfactorreceptorchimericantibodyC225aloneandcombina2tionwithcisplatin[J].JClinOncol,2000,18:904-914.

[27]　KarpDD,SlibermanSL,CsudaeR,etal.PhaseIdoseescalcation

studyofepidermalgrowthfactorreceptor(EGFR)tyrosinekinase(TK)inhibitorCP-358,774inpatientswithadvancedsolidtumors[J].ProcAmSocClinOncol,1999,18:388a(abstr1499).

[28]　HidalgoM,SiuLL,NemunaitisJ,etal.PhaseIandphar2macologic

studyofOSI-774,anepidermalgrowthfactorreceptortyrosineki2naseinibitor,inpatientswithadvancedsolidmalignancies[J].JClinOncol,2001,19:3267-3279.

[29]　Perez2SolerR,ChachouaA,HubermanM,etal.APhaseIItrialofthe

epidermalgrowthfactorreceptor(EGFR)tyrosinekinaseinhibitorOSI2774,followingplatinum2basedchemotherapy,inpatients(pts)withadvanced,EGFR2expressing,non2smallcelllungcancer(NSCLC)[J].ProcAmSocClinOncol,2001,20:310a(A1235).

[30]　FerryD,HammondL,RansonM,etal.IntermittentoralZD1839(Ires2

sa),anovelepidermalgrowthfactorreceptortyrosinekinaseinhibitor

[1]　ParkinDM,BrayFI,DevesaSS.Cancerburdenintheyear2000.The

globalpicture[J].EurJCancer2001,37(8):S4-S66.

[2]　FranklinWA,VeveR,HirschFR,etal.Epidermalgrowthfactorre2

ceptorfamilyinlungcancerandpremalignancy[J].SeminOncol,2002,29(1):3-14.

[3]　RaymondE,FaivreS,ArmandJP.Epidermalgrowthfactorreceptor

tyrosinekinaseasatargetforanticancertherapy[J].Drugs,2000(4):15-23.

[4]　DebTB,SuL,WongL,etal.F)torkinase2byJBiol,2001,276(18):15554-15560.

[5]　JoseBaselag.WhytheEpidermalGrowthFactorReceptor?TheRa2

tionaleforCancerTherapy[J].TheOncologist,2002,7(4):2-8.[6]　BergstromJD,WestermarkB,HeldinNE.Epidermalgrowthfactorre2

ceptorsignalingactivatesmetinhumananaplasticthyroidcarcinomacells[J].ExpCellRes,2000,259(l):293-299.

[7]　DenningMF,DlugoszAA,ChengC,etal.Cross2talkbetweenepider2

malgrowthfactorreceptorandproteinkinaseCduringcalcium2in2duceddifferentiationofkeratinocytes[J].ExpDermatol,2000,9(3),192-199.

[8]　Min2JeongOh,Jin2HyukChoi,InHoKim,etal.DetectionofEpider2

malGrowthFactorReceptorintheSerumofPatientswithCervicalCarcinoma[J].ClinicalCancerResearch,2000,6,4760-4763.

[9]　KimHG,KassisJ,SoutoJC,etal.EGFreceptorsignalinginprostste

morphogenesisandtumorigenesis[J].HistolHistopathol,1999,14(4):1175-1182.

[10]　ChandrikaJ,Piyathilake,AndraR,etal.DifferentialExpressionof

GrowthFactorsinSquamousCellCarcinomaandPrecancerousLesionsoftheLung[J].ClinicalCancerResearch,2002,8(3):734-744.[11]　PolosaR,ProsperiniG,LeirSH,etal.Expressionofc-erbBrecep2

torsandligandsinhumanbronchialmucosa[J].AmJRespirCellMolBiol,1999,20(5):914-923.

[12]　MilasI,KomakiR,HachiyaT,etal.Epidermalgrowthfactorrecep2

tor,cyclooxyenase-2,andBAXexpressionintheprimarynon2smallcelllungcancerandbrainmetastases[J].ClinCancerRes,2003,9(3):1070-1076.

[13]　PeterTR,HironobuK,RobertA,etal.Amplificationandoverexpres2

sionofthecyclinD1andepidermalgrowthfactorreceptorgenesinnon2small2celllungcancer[J].JCancerResClinOncol,1999,125:61-70.

[14]　NicholsonRI,GeeJMW,HarperME.EGFRandcancerprognosis[J].

EuropeanJournalofCancer,2001,37(4):9-15.

[15]　AlbanelJ,RojoF,AverbuchS,etal.Pharmacodynamicstudiesofthe

epidermalgrowthfactorreceptorinhibitorZD1839inskinfromcancerpatients:Histopathologicandmolecularconsequencesofreceptorinhi2bition[J].JClinOncol,2002,20:110-124.

[16]　SpauldingDC,SpauldingBO.Epidermalgrowthfactorreceptorexpres2

sionandmeasurementinsolidtumors[J].SeminOncol,2002,29(5